D. E. Shaw & Co., Inc. Teva Pharmaceutical Industries LTD Call Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $204,480 - $278,400	-16,000 Reduced 3.76%	409,700 $6.66 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $4.15 Million - $5.62 Million	389,400 Added 1072.73%	425,700 $6.01 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $303,468 - $412,731	36,300 New	36,300 $321,000
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $3.4 Million - $5.04 Million	-397,100 Reduced 57.21%	297,000 $2.68 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $3.66 Million - $5.91 Million	-450,300 Reduced 39.35%	694,100 $8.56 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $745,935 - $1.5 Million	-111,500 Reduced 8.88%	1,144,400 $10.3 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $2.59 Million - $4.25 Million	396,200 Added 46.09%	1,255,900 $12.3 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $3.41 Million - $5.32 Million	554,100 Added 181.32%	859,700 $5.92 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $4.32 Million - $8.36 Million	-531,500 Reduced 63.49%	305,600 $2.82 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $755,630 - $970,485	-48,500 Reduced 5.48%	837,100 $13.1 Million
Q4 2018 Feb 14, 2019	SELL	$14.59 - $23.84 $1.07 Million - $1.74 Million	-73,000 Reduced 7.62%	885,600 $13.7 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $269,568 - $328,320	-12,800 Reduced 1.32%	958,600 $20.6 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $4.99 Million - $7.36 Million	297,800 Added 44.21%	971,400 $23.6 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $5.72 Million - $7.57 Million	343,000 Added 103.75%	673,600 $11.5 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $1.69 Million - $2.87 Million	150,500 Added 83.56%	330,600 $6.27 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $2.78 Million - $5.79 Million	180,100	180,100 $3.17 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

Black Rock Inc. New York, NY

43M
Shares

$752 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.3M
Shares

$636 Million
41.14% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

32.3M
Shares

$566 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$505 Million
3.23% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$463 Million
15.49% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account